Premium
P1‐503: REASONS FOR REFUSING COGNITIVE TESTING AMONG OLDER ADULTS
Author(s) -
Smith Samantha,
Wong Sara,
Jacova Claudia
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.1108
Subject(s) - worry , cognition , test (biology) , cognitive test , psychology , computerized adaptive testing , logistic regression , clinical psychology , gerontology , medicine , psychiatry , psychometrics , anxiety , paleontology , biology
are commonly used to treat neuropsychiatric symptoms of dementia. 86.7 % of NPS patients are on acetylcholinesterase inhibitors, psychotropic, antidepressant or anxiolytic medications. (Table 3). Conclusions: Psychotropic agent use in community dwelling patients with NPS is very common. Despite concerns that their risks (eg, infection, falls, death) may outweigh their benefits, These agents are necessary for the family and caregiver to help control patients behavior to continue to live in the community setting.